Which Screening Is Used to Test for Breast Cancer?

Mammography is the primary screening tool used to test for breast cancer. It remains the only screening method proven to reduce breast cancer deaths in large clinical trials, with studies showing a 25% relative reduction in mortality during the first 10 years of regular screening. For most women at average risk, the U.S. Preventive Services Task Force recommends a mammogram every two years starting at age 40 and continuing through age 74.

How Mammography Works

A mammogram uses low-dose X-rays to create images of breast tissue, allowing radiologists to spot abnormal masses, clusters of tiny calcium deposits, and other changes that could signal cancer. The procedure takes about 15 to 20 minutes. Each breast is compressed between two plates to spread the tissue thin enough for clear imaging.

Mammography’s accuracy improves with age because breast tissue naturally becomes less dense over time. In women ages 40 to 49, mammograms correctly identify about 87% of cancers present. That figure climbs to roughly 94% for women in their 60s. Specificity, the ability to correctly rule out cancer when it isn’t there, stays consistently high across all age groups at 93% to 95%.

3D Mammography vs. Standard 2D

Most screening facilities now offer 3D mammography, also called digital breast tomosynthesis. Instead of taking a single flat image, the machine sweeps in an arc around the breast and captures multiple thin slices, which a computer assembles into a three-dimensional picture. This makes it easier to distinguish a real mass from overlapping layers of normal tissue.

Research from Yale School of Medicine found that 3D mammography detects 5.3 cancers per 1,000 screenings compared to 4 per 1,000 with standard 2D imaging. It also catches cancers at an earlier stage without increasing overdiagnosis of slow-growing tumors that would never cause harm. False positive rates drop meaningfully too: 7.2% with 3D versus 10.6% with 2D. That difference translates to fewer women getting called back for unnecessary follow-up testing. The American College of Radiology now recommends 3D mammography for all women regardless of risk level or breast density.

Screening for Dense Breast Tissue

About half of women who get mammograms have dense breasts, meaning their tissue contains more fibrous and glandular tissue relative to fat. Dense tissue appears white on a mammogram, and so do tumors, which makes cancers harder to spot. Breast density is classified into four categories: almost entirely fatty, scattered fibroglandular elements, heterogeneously dense, and extremely dense. If you fall into either of the two densest categories, your screening results letter will tell you.

For women with dense breasts, supplemental screening beyond a standard mammogram can help. The options depend on how dense your tissue is and your overall risk level:

  • Breast ultrasound uses sound waves to create images and can find solid masses hidden by dense tissue. It’s considered an appropriate add-on for women with dense breasts, though it does come with higher false positive rates, meaning more chances of being called back for something that turns out to be benign.
  • Breast MRI uses magnetic fields and contrast dye to produce highly detailed images. For women with extremely dense breasts, MRI is considered appropriate even at average risk. A large Dutch trial (the DENSE trial) found that adding MRI for women with extremely dense tissue significantly improved cancer detection and lowered the rate of cancers found between screenings.
  • Contrast-enhanced mammography is a newer option that combines a standard mammogram with an iodine-based contrast dye injected into a vein. The dye highlights areas where tumors are building new blood vessels. Studies show it matches the sensitivity of breast MRI at around 96% to 97%, while being faster and less expensive. It’s gaining traction as a supplemental tool for women with dense breasts or a history of breast cancer.

Who Needs MRI Screening

Women with a lifetime breast cancer risk of 20% or higher are recommended to get an annual breast MRI in addition to an annual mammogram. This high-risk group includes women who carry BRCA1 or BRCA2 gene mutations, women who haven’t been tested but have a first-degree relative (mother, sister, daughter) with a known BRCA mutation, and women who received radiation to the chest between ages 10 and 30.

For these women, mammography alone isn’t sufficient. MRI picks up cancers that mammograms miss, particularly in younger women whose breast tissue tends to be denser. The two tests complement each other because they detect different types of abnormalities. Screening MRI is typically alternated with mammography so that one or the other happens every six months.

Understanding Your Results

Mammogram results are reported using a standardized scoring system called BI-RADS, with categories numbered 0 through 6. Knowing what your score means can save you a lot of anxiety.

  • BI-RADS 0 (Incomplete): The radiologist needs additional images to evaluate a possible finding. You’ll be called back for a diagnostic mammogram, ultrasound, or comparison with older images. This is common and usually not cause for alarm.
  • BI-RADS 1 (Negative): No abnormalities found. Continue routine screening.
  • BI-RADS 2 (Benign): A finding is present but clearly noncancerous, such as a cyst or calcification. Continue routine screening.
  • BI-RADS 3 (Probably benign): The finding has a greater than 98% chance of being noncancerous, but a follow-up in six months is recommended to confirm it hasn’t changed.
  • BI-RADS 4 (Suspicious): The finding has features that could indicate cancer, with anywhere from a 2% to 95% chance. A biopsy is recommended.
  • BI-RADS 5 (Highly suggestive of cancer): The finding looks very likely to be cancer. A biopsy is needed promptly.
  • BI-RADS 6 (Known cancer): Cancer has already been confirmed by a previous biopsy. This score appears only when imaging is done to guide treatment planning.

What Happens After an Abnormal Result

If your mammogram flags something suspicious, the next step is usually diagnostic imaging: a closer mammogram focused on the area of concern, an ultrasound, or both. If the finding still looks suspicious, a biopsy is needed to determine whether cancer cells are present.

The most common type is a core needle biopsy, where a larger needle removes small cylinders of tissue from the area. It doesn’t require a surgical incision and is typically done with local numbing in an outpatient setting. For smaller or harder-to-reach areas, a vacuum-assisted biopsy uses a hollow probe guided by imaging to gently pull tissue samples through a small skin opening. Fine needle aspiration, which uses a very thin needle to extract fluid or a small tissue sample, is sometimes used to determine whether a lump is a fluid-filled cyst or a solid mass. Most biopsy results come back within a few days.

How to Prepare for a Mammogram

Skip deodorant and antiperspirant on the day of your appointment. Most formulas contain aluminum, which shows up as tiny white specks on the images and can mimic the appearance of calcifications. If you forget, the technologist can provide wipes to clean it off before the exam.

Wear a two-piece outfit since you’ll need to undress from the waist up. Leave necklaces and earrings at home to avoid the hassle of removing and keeping track of them. If you menstruate, try to schedule your appointment for the week or two after your period ends. Breasts are most tender the week before and during menstruation, and compression during those times can be more uncomfortable than it needs to be.